Strain-dependent differences in sensitivity of rat β-cells to interleukin 1β in vitro and in vivo: Association with islet nitric oxide synthesis

Diabetes

Volumn 45, Issue 6, 1996, Pages 771-778

  Reimers, Jesper I ^a   Andersen, Henrik U ^a   Mauricio, Dídac ^a   Pociot, Flemming ^a   Karlsen, Allan E ^a   Petersen, Jacob S ^a   Mandrup Poulsen, Thomas ^a   Nerup, Jørn ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCAGON; INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT INTERLEUKIN 1BETA; RESTRICTION ENDONUCLEASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FOOD INTAKE; GLUCAGON BLOOD LEVEL; HORMONE RESPONSE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE;

EID: 0029922662     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.45.6.771     Document Type: Article

References (33)

1. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers J, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T: On the pathogenesis of IDDM. Diabetologia 37 (Suppl. 2):S82-S89, 1994
2. Sandler S, Eizirik DL, Svensson C, Strandell E, Welsh M, Welsh N: Biochemical and molecular actions of interleukin-1 on pancreatic β-cells. Autoimmunity 10:241-253, 1991
3. Corbett JA, McDaniel ML: Does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 41:897-903, 1992
4. Wogensen L, Reimers J, Nerup J, Kolb-Bachofen V, Kroncke K-D, Almdal T, Mandrup, Poulsen T: Repetitive in vivo treatment with human recombinant interleukin-1β modifies beta-cell function in normal rats. Diabetologia 35:331-339, 1992
5. Jiang Z, Woda BA: Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J Immunol 146:2990-2994, 1991
6. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C: Genes encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad USA 87:2239-2243, 1990
7. Dayer-Metroz M-D, Duhamel D, Rufer N, Izui S, Carmichals D, Wolheim CB, Thompson RC, Dayer J-M: IL-1 receptor antagonist delays spontaneous autoimmune diabetes in BB rats (Abstract). Eur J Clin Invest 22:A50, 1992
8. Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Moroni PL: Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol 24:1843-1847, 1994
9. Karlsen AE, Andersen HU, Vissing H, Larsen PM, Fey SJ, Cuartero BG, Madsen OD, Petersen JS, Mortensen SB, Mandrup-Poulsen T, Boel E, Nerup J: Cloning and expression of cytokine inducible nitric oxide synthase cDNA from rat islets of Langerhans. Diabetes 44:753-758, 1995
10. Southern C, Schulster D, Green IC: Inhibition of insulin secretion by interleukin-1β and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276:42-44, 1990
11. Welsh N, Eizirik DL, Bendtzen K, Sandler S: Interleukin-1β- induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129:3167-3173, 1991
12. G-monomethyl-L-arginine. FEBS Lett 299:103-106, 1992
13. Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML: Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41:552-056, 1992
14. Reimers JI, Bjerre U, Mandrup-Poulsen T, Nerup J: Interleukin-1β induces diabetes and fever in normal rats by nitric oxide via induction of different nitric oxide synthases. Cytokine 6:512-520, 1994
15. Andersen HU, Jørgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J: Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43:770-777, 1994
16. Andersen HU, Mandrup-Poulsen T, Egeberg J, Helqvist S, Nerup J: Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat. Acta Endocrinol 120:92-98, 1989
17. Dalbøge H, Bayne S, Christensen T, Hejnæs K. Cloning and expression of an interleukin-1β precursor and its conversion to interleukin-1β. FEBS Lett 246:89-93, 1989
18. Mølvig J, Sehested Hansen B, Worsaae H, Hejnæs K, Helle M, Dalbøge H, Nerup J: Comparison of biological and immunological activities of human monocyte-derived interleukin 1β and human recombinant interleukin 1β. Scand J Immunol 31:225-235, 1990
19. Brunstedt J, Nielsen JH, Lernmark A, Hagedorn Study Group: Isolation of islets from mice and rats. In Methods in Diabetes Research. Vol 1. Larner J, Pohl SL, Eds. New York, Wiley, 1984, p. 254-288
20. 15N]nitrate in biological fluids. Anal Biochem 126:131-138, 1982
21. Heding LG: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8:260-266, 1972
22. Heding LG: Radioimmunological determination of pancreatic and gut glucagon in plasma. Diabetolagia 7:10-19, 1971
23. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Bärmaier H, Mathewes S, Grant FJ, Foster D, Lernmark Å: Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acid Sci USA 88:8337-8341, 1991
24. Petersen JS, Karlsen AE, Markholst H, Worsaae A, Dyrberg T, Michelsen B: Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice. Diabetes 44:1478-1484, 1994
25. Mandrup-Poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jørgensen DW, Bendtzen K, Nielsen JH, Nerup J: Islet cytoxicity of interleukin-1: influence of culture conditions and islet donor characteristics. Diabetes 36:641-647, 1987
26. Eizirik DL, Welsh M, Strandell E, Welsh N, Sandler S: Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 127:2290-2297, 1990
27. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A: Major species differences between human and rodents in the susceptibility to pancreatic β-cell injury. Proc Natl Acad Sci USA 91:9253-9256, 1994
28. Corbett JA, McDaniel ML: Intraislet release of interleukin 1 inhibits β cell function by inducing β cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568, 1995
29. Fu Y, Blackenhorn EP: Nitric-oxide-induced anti-mitogenic effects in high and low responder rat strains. J Immunol 148:2217-2222, 1992
30. Palmer JP, Helqvist S, Spinas GA, Mølvig J, Mandrup-Poulsen T, Andersen HU, Nerup J: Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 38:1211-1216, 1989
31. Andersen HU, Mauricio D, Karlsen AE, Mandrup-Poulsen T, Nielsen JH, Nerup J: Interleukin-1β-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-1-methyl xanthine. Eur J Endocrinol 134:251-259, 1996
32. Perretti M, Duncan GS, Flower RJ, Peers SH: Serum corticosterone, interleukin-1 and tumor necrosis factor in rat experimental endotoxaemia: comparison between Lewis and Wistar rats. Br J Pharmacol 110:868-874, 1993
33. Prins J-B, Herberg L, Bieman MD, van Zutpen BFM: Genetic characterisation and interrelationship of inbred lines of diabetes-prone and not diabetes-prone BB rats. In Frontiers in Diabetes Research: Lessons From Animal Diabetes III. Shafrir E, Ed. Smith-Gordon 1990, p. 19-24